By W. Gifford-Jones, MD and Diana Gifford-Jones —— Bio and Archives--September 9, 2016
Doctors have stressed for years it’s vital to treat all cancers early to increase the chance of cure. But one rogue malignancy rarely obeys the rules. Now, a report in the Canadian Medical Association Journal says, “active surveillance” is increasingly used to treat prostate cancer. The big question is how many patients want to wait when told they have a malignancy?
But why is this currently a choice? Autopsies show that 50 percent of men over age 59 have prostate cancer, and three in four over 85. One in seven North Americans will be diagnosed with prostate cancer in their lifetime, yet only one in every 28 men will die of it. Obviously, not all need to be treated.The Comment section of online publications is the new front in the ongoing Cancel Culture Battle.
Big Tech and Big Media are gunning for the Conservative Voice—through their Comment Sections.
Canada Free Press wishes to stay in the fight, and we want our fans, followers, commenters there with us.
We ask only that commenters keep it civil, keep it clean.
Thank You for your patience and for staying aboard the CFP ‘Mother Ship’.
READ OUR Commenting Policy
Support Canada Free Press
